WITHDRAWN:Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure.
Ahead of Print article withdrawn by publisher.
Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.|Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea.
Kyoung Min
KM
Cho
Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.|Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Bhumsuk
B
Keam
Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.|Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Tae Min
TM
Kim
Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.|Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Se-Hoon
SH
Lee
Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.|Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Dong-Wan
DW
Kim
Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.|Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Dae Seog
DS
Heo